Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma

BACKGROUND: Advanced inoperable hepatocellular carcinoma (HCC) conferring a grave prognosis may benefit from yttrium-90 ((90)Y) radioembolization. METHODS: Thirty patients with advanced inoperable HCC including those with any lesion >8 cm in maximal diameter or multiple bi-lobar lesions (totally...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Victor Ho-Fun, Leung, Dennis KC, Luk, Mai-Yee, Tong, Chi-Chung, Law, Martin WM, Ng, Sherry CY, Wong, Ka-Kin, Poon, Ronnie TP, Kwong, Dora LW, Leung, To-Wai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662370/
https://www.ncbi.nlm.nih.gov/pubmed/26640386
http://dx.doi.org/10.2147/OTT.S92473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662370/
https://www.ncbi.nlm.nih.gov/pubmed/26640386
http://dx.doi.org/10.2147/OTT.S92473

Ejemplares similares